ReviewBMJ (Clinical research ed.)2005
How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?
Nick FreemantlePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it